期刊
JOURNAL OF WATER PROCESS ENGINEERING
卷 32, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jwpe.2019.100927
关键词
Pharmaceutically active compounds; PhACs; Water treatment; Wastewater treatment; Risk assessment; Emerging pollutants
资金
- Coordination of Superior Level Staff Improvement (CAPES)
- National Council for Scientific and Technological Development (CNPq)
- Foundation for Research Support of the State of Minas Gerais (FAPEMIG)
- Federal University of Minas Gerais, Brazil (UFMG)
This paper reviews the occurrence of Pharmaceutically active compounds (PhACs) in water and wastewater worldwide as well as their fate, focusing on the removal by conventional water and wastewater treatment plants and the risk imposed to human health associated to the presence of PhACs in raw and drinking water. For this, it was assessed 23 drinking water treatment plants and 30 municipal wastewater treatment plants around the world of different capacities. Due to the high stability, intrinsic characteristics and low concentration, adsorption to the sludge and biodegradation are the most used path to remove of these compounds in wastewater treatment plants (WWTP). In water treatment plants (WTP), chlorination and application of activated granular carbon are the processes associated with the highest removal of pharmaceutical compounds, but, in general, conventional WTPs are able to reduce but not completely remove PhACs in potable water. Carbamazepine, gemfizobril and fenofibrate are found to be the PhACs that risks to human health could not be excluded. This indicates the necessity of investments in advanced techniques for the treatment of water and wastewater. The results also point to the need for more studies focusing on the determination of guideline values for drinking water of more PhACs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据